CTA-PA — EIDP, Inc.

Corteva Agriscience Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Performance: Organic sales decreased by 4% year-over-year, with Crop Protection volumes down 2% and prices down 1%. Seed prices increased by 3%, but volumes fell by 8% due to timing shifts.
• Full Year Results: Organic sales increased by 4%, with operating EBITDA rising 14% to $3.85 billion, achieving a margin of over 22%, up 215 basis points from the previous year. Free cash flow improved significantly to $2.9 billion, driven by higher earnings and working capital discipline.
• SG&A and R&D Expenses: SG&A rose from $735 million to $860 million due to higher compensation expenses; R&D increased by $50 million, aligning with the company's target of over 8% of sales.

2. Strategic Updates and Business Highlights

• Separation Update: Corteva is on track for a corporate separation in Q4 2026, with a global CEO search underway and plans to announce the new brand identity for SpinCo.
• Bayer Agreement: A comprehensive resolution with Bayer enhances Corteva's licensing capabilities, allowing for accelerated corn licensing as early as 2027 and entry into the cotton market. This is expected to generate approximately $1 billion in earnings upside over the next decade.
• Seed Business Performance: The Seed segment saw organic growth across all regions, with notable gains in corn and soybeans, and achieved $340 million in net cost improvements.
• Crop Protection Pipeline: The Crop Protection business has a robust $9 billion pipeline, with significant productivity and cost benefits contributing to resilience amid competitive pricing dynamics.

3. Forward Guidance and Outlook

• 2026 Guidance: Corteva expects operating EBITDA to be between $4 billion and $4.2 billion, reflecting a 7% growth at the midpoint. The guidance includes anticipated growth in Seed licensing and Crop Protection volumes, alongside productivity benefits.
• Market Dynamics: The company anticipates modest growth in the Crop Protection market, with pricing pressures continuing, particularly in Latin America. Seed volumes are expected to be flat due to shifts in crop planting.

4. Challenges and Points of Concern

• Volume Declines: The decline in volumes for both Seed and Crop Protection in Q4 raises concerns about demand and market conditions.
• Pricing Pressures: Competitive pricing dynamics, especially in Latin America, are expected to persist, impacting margins.
• Tariff Headwinds: An estimated $80 million impact from tariffs is anticipated, which could affect profitability.
• Farmer Financial Stress: High interest rates and suppressed commodity prices are creating cash flow challenges for farmers, potentially impacting future purchasing behavior.

5. Notable Q&A Insights

• Bayer Agreement Clarifications: The agreement allows Corteva to accelerate its licensing business and provides clarity on existing litigation, enhancing operational certainty.
• Gene Editing Developments: There is optimism regarding the EU's potential regulatory changes that could facilitate the introduction of gene-edited seeds, which Corteva views as a significant opportunity.
• Market Share Gains: Corteva reported continued share gains in corn and soybeans in North America and Brazil, with expectations to double market share for Conkesta soybeans in 2026.
• Free Cash Flow Expectations: While 2025 saw exceptional free cash flow, normalization is expected in 2026 due to working capital adjustments and separation costs.

Overall, Corteva's Q4 2025 results reflect a strong year with significant strategic advancements, though challenges remain in market dynamics and pricing pressures. The outlook for 2026 is cautiously optimistic, with a focus on maintaining growth and managing operational efficiencies.